Comparing Methoxyflurane Inhalation and Virtual Reality Headset to Standard Pain Management for Reducing Anterior Shoulder Dislocation

What this Trial Is About

Anterior shoulder dislocation is a common emergency condition that requires effective pain control for successful reduction. Researchers are evaluating different pain management techniques, including methoxyflurane inhalation and virtual reality headsets, compared to standard analgesic treatments. The study aims to find the best method to reduce pain and muscle tension during the shoulder reduction process, potentially avoiding the need for procedural sedation. Participants will be randomly assigned to one of three groups standard care using paracetamol and oxygennitrous oxide mixture, use of a virtual reality headset with HypnoVR software during the procedure, or self-administered inhaled methoxyflurane with a maximum dose of 3 mL. Each group receives their assigned analgesic approach before and during the shoulder dislocation reduction. During the study, participants will undergo the reduction procedure while researchers monitor pain levels, procedural sedation rates, medication use, procedure duration, and patient satisfaction. Follow-up assessments up to three months will evaluate medication use, complications related to the reduction, and emergency department stay length. The study tracks immediate and longer-term outcomes to understand how these analgesic methods affect recovery and patient experience.

METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX)